Our team draws on deep industry expertise, clinical insights, and cross-asset class investing experience to drive advances in pharmaceuticals, biotechnology, medical devices, diagnostics, and life science tools to improve the lives of patients with unmet medical needs.
Carlcorp Life Sciences invests in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe, with a focus on companies that both drive medical innovation across the value chain and enable that innovation to improve the lives of patients with unmet medical needs. The differentiated skillset of Carlcorp Life Sciences team enables it to deliver targeted capital and value-added strategic support to companies around critical phases of growth and inflections in value.
Since 2000, Carlcorp has employed a strategic and analytical approach to identify attractive investment opportunities and partner with management teams to transform and improve their businesses. During this time, Carlcorp has developed global reach, deep expertise, and a proven track record in the life sciences industries across private equity, public equity, credit, venture capital, and real estate.
We have built one of the largest and deepest healthcare investing teams in the world.
Carlcorp Life Sciences targets four types of investment opportunities:
Engaging with companies at the critical development stages of innovation.
Partnering with companies to accelerate and expand platforms.
Engaging with companies at a crossroads to create value.
Leveraging the Carlcorp platform to invest in, build, and support companies.
Management teams that deploy capital efficiently to scale their business.
Join the growing number of investors who align their money with their values.Get Started Now